Fortress Biotech (FBIO) Revenue Growth (1y) (2016 - 2026)
Powered by 
Analysis
Fortress Biotech (FBIO) Revenue Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 12.45% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 16.73% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 59.71% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 2.11% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 29.63% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 66.86% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 16.50% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 296.11% |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 14.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.04% |
| Dec 31, 2025 | 6.34% |
| Sep 30, 2025 | 20.52% |
| Jun 30, 2025 | 10.18% |
| Mar 31, 2025 | 0.84% |
| Dec 31, 2024 | -24.20% |
| Sep 30, 2024 | -57.90% |
| Jun 30, 2024 | -14.32% |
| Mar 31, 2024 | 4.84% |
| Dec 31, 2023 | 21.59% |
| Sep 30, 2023 | 110.26% |
| Jun 30, 2023 | -4.66% |
| Mar 31, 2023 | -48.05% |
| Dec 31, 2022 | -10.24% |
| Sep 30, 2022 | -21.61% |
| Jun 30, 2022 | 2.20% |
| Mar 31, 2022 | 106.48% |
| Dec 31, 2021 | 32.93% |
| Sep 30, 2021 | 122.53% |
| Jun 30, 2021 | 88.68% |